← All organizations
Highest phase reached
Phase 2
Timeline
1990s
- Jan 1, 1999
Soleno Therapeutics, Inc.— Founded
2010s
- Dec 27, 2016
Essentialis, Inc.— Acquired
2020s
- Mar 26, 2025
diazoxide choline— Marketing Organization
Drugs by trial phase (5 distinct, 22 trials)
Phase 3 (0 own, 3 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (16)
- NCT05701774Lead sponsorPhase 3Jan 31, 2023
- NCT05532020Lead sponsorPhase 2Jan 31, 2023
- NCT04086810Lead sponsorPhase 3Oct 15, 2019
- NCT03714373Lead sponsorPhase 3Oct 1, 2018
- NCT03440814Lead sponsorPhase 3May 9, 2018
- NCT02473016Lead sponsorPhase 2Sep 1, 2015
- NCT02381795CollaboratorPhase 2Jul 1, 2015
- NCT01253915Lead sponsorPhase 2Jan 1, 2012
- NCT00917020Lead sponsorPhase 2Jul 1, 2009
- NCT00917111Lead sponsorPhase 2Jul 1, 2009
- NCT00917111Study directorPhase 2Jul 1, 2009
- NCT00917020Study directorPhase 2Jul 1, 2009
- NCT00690716Lead sponsorPhase 2Aug 1, 2008
- NCT00688441Lead sponsorPhase 2Jul 1, 2008
- NCT00638755Lead sponsorPhase 2Feb 1, 2008
Details
- Founded
- Redwood City, CA, US Jan 1, 1999
- Last known activity
- Mar 26, 2025
Notes
--- Pre-folding founded info: 2017-01-01 Redwood City CA US https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=2520553 ---